The Protecting Americans from Unsafe Drugs Act of 2026 expands the FDA's authority to recall unsafe medications by extending rules previously limited to controlled substances to all drugs. Currently, the FDA has broad recall powers specifically for controlled substances, but this bill removes that restriction so the agency can more quickly order the removal and halt distribution of any unsafe drug from the market. The legislation also clarifies that the Director of the Center for Biologics Evaluation and Research can participate in these recall decisions alongside other FDA officials, and extends recall authority to cover imported and exported drugs. The bill aims to give the FDA faster tools to protect the public from dangerous medications regardless of whether they are controlled substances, though no new funding or specific timeline is mentioned in the text provided.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.